Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab

J Neurooncol. 2015 Nov;125(2):445-6. doi: 10.1007/s11060-015-1925-8. Epub 2015 Sep 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Ependymoma* / complications
  • Ependymoma* / diagnostic imaging
  • Ependymoma* / drug therapy
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neurofibromatosis 2 / complications
  • Neurofibromatosis 2 / drug therapy*
  • Radiography
  • Spinal Cord Neoplasms* / complications
  • Spinal Cord Neoplasms* / diagnostic imaging
  • Spinal Cord Neoplasms* / drug therapy

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab